Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M110947200 on April 30, 2002

J. Biol. Chem., Vol. 277, Issue 27, 24265-24273, July 5, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/27/24265    most recent
M110947200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Startchik, I.
Right arrow Articles by Rossier, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Startchik, I.
Right arrow Articles by Rossier, M. F.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Control of Calcium Homeostasis by Angiotensin II in Adrenal Glomerulosa Cells through Activation of p38 MAPK*

Irina StartchikDagger , Dominique MorabitoDagger , Ursula LangDagger , and Michel F. RossierDagger §

From the Dagger  Division of Endocrinology and Diabetology, Department of Internal Medicine, and the § Laboratory of Clinical Chemistry, Department of Pathology, University Hospital, CH-1211 Geneva 14, Switzerland

Received for publication, November 15, 2001, and in revised form, March 26, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Angiotensin II-induced activation of aldosterone secretion in adrenal glomerulosa cells is mediated by an increase of intracellular calcium. We describe here a new Ca2+-regulatory pathway involving the inhibition by angiotensin II of calcium extrusion through the Na+/Ca2+ exchanger. Caffeine reduced both the angiotensin II-induced calcium signal and aldosterone production in bovine glomerulosa cells. These effects were independent of cAMP or calcium release from intracellular stores. The calcium response to angiotensin II was more sensitive to caffeine than the response to potassium, suggesting that the drug interacts with a pathway specifically elicited by the hormone. In calcium-free medium, calcium returned more rapidly to basal levels after angiotensin II stimulation in the presence of caffeine. Thapsigargin had no effect on these kinetics, but diltiazem, which inhibits the Na+/Ca2+ exchanger, markedly reduced the rate of calcium decrease and abolished caffeine action. The involvement of this exchanger was supported by the effect of cell depolarization and of a reduction of extracellular sodium on the rate of calcium extrusion. We also determined the mechanism of angiotensin II action on the exchanger. Phorbol esters reduced the rate of calcium extrusion, which was increased by baicalein, an inhibitor of lipoxygenases, and by SB 203580, an inhibitor of the p38 MAPK. Finally, we showed that angiotensin II acutely activates, in a caffeine-sensitive manner, p38 MAPK in glomerulosa cells. In conclusion, in bovine glomerulosa cells, the Na+/Ca2+ exchanger plays a crucial role in extruding calcium, and, by reducing its activity, angiotensin II influences the amplitude of the calcium signal. The hormone exerts its action on the exchanger through a caffeine-sensitive pathway involving the p38 MAPK and lipoxygenase products.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

It has been firmly established that cellular calcium signaling in bovine adrenal glomerulosa cells plays a crucial role upon stimulation of aldosterone production by angiotensin II (AngII)1 or extracellular potassium, and the mechanisms of calcium mobilization by these agonists have been reviewed in detail (1-3). Whereas K+ principally activates voltage-operated calcium channels of both L and T type through direct membrane depolarization (4), the Ca2+ response to AngII appears biphasic; a first acute elevation of [Ca2+]c due to Ca2+ release from intracellular stores is followed by a sustained response reflecting the activation of Ca2+ influx through channels of the plasma membrane. This second phase is maintained by the activity of both voltage-gated and store-operated Ca2+ channels.

Beside these basic pathways of Ca2+ mobilization, additional mechanisms have been proposed to participate or to modulate the Ca2+ signal elicited by AngII in bovine adrenal glomerulosa cells. For example, the participation of the Na+/Ca2+ exchanger (NCX) in Ca2+ transport (in one direction or the other) during cell exposure to AngII has been suggested (2, 5). Moreover, the protein kinase C (PKC) wing of AngII signaling probably also regulates, directly or indirectly, the Ca2+ messenger system. Although it was proposed earlier that activation of this enzyme is essential for the steroidogenic response to Ca2+-mobilizing hormones (6), the same authors reported an inhibition of the phospholipase C by the phorbol ester phorbol 12-myristate 13-acetate (PMA) (7), and the activation of PKC has been also shown to be responsible for acute inhibition of T type Ca2+ channels (8).

In addition to the phospholipase C-mediated formation of diacylglycerol, AngII also stimulates the production of arachidonic acid by activation of a phospholipase A2 (9) or from diacylglycerol through a diacylglycerol lipase (10). However, there is scant information concerning the exact relationship between PKC, phospholipase A2, and diacylglycerol lipase in steroidogenic cells. Nevertheless, arachidonic acid serves as a substrate for various enzymes that will further convert it into leukotrienes, prostaglandins, or hydroxyeicosatetraenoic acids (HETEs). The latter, and more specifically the 12-lipoxygenase products, have been proposed for many years to play an important role in aldosterone synthesis (11, 12). Interestingly, 12-HETE appears to be directly involved in the generation of the AngII-elicited Ca2+ signal, because this response is prevented by lipoxygenase blockers such as baicalein and restored by the addition of 12-HETE (13).

Mitogen-activated protein kinases (MAPKs) are a family of ubiquitous and highly conserved serine-threonine protein kinases activated by diverse stimuli ranging from cytokines, growth factors, neurotransmitters, hormones, cellular stress, and cell adherence (14). Mammalian MAPKs have been classified in three groups, which differ in their activation pathway and include the MAPK extracellular signal-regulated kinase (also referred as p42/44 MAPK), the MAPK c-Jun N-terminal kinase, and the MAPK p38. Angiotensin II, through its AT1 receptor, has been shown to activate p42/44 MAPK in bovine adrenal fasciculata cells (15) as well as in bovine and rat glomerulosa cells (16, 17), an effect probably linked to the action of this hormone on cell proliferation (18). This activation, easily detected by measuring the phosphorylated forms of the enzymes, is maximal after a few minutes and appears mediated by various effectors including PKC and the Ras/Raf-1 kinase pathway (19).

In contrast, the activation of the p38 MAPK by AngII in glomerulosa cells is poorly documented, despite the fact that the hormone has been shown to induce an increase in p38 activity in vascular smooth muscle cells, particularly under high glucose conditions (20). Recently, it has been reported that AngII leads to a dose-dependent increase in p38 MAPK activity in H295R adrenocortical cells, an effect mimicked by the addition of 12-HETE (21). In contrast, no action of the hormone was observed on the activity of the stress-activated MAPK c-Jun N-terminal kinase. The authors also indicate that AngII-induced aldosterone stimulation was significantly attenuated by a specific p38 MAPK inhibitor but not by an inhibitor of the MEK/ERK pathway.

In the present study, we have analyzed the mechanisms by which caffeine, a drug known to interfere with multiple targets involved in cell signaling, exerts its action on the intracellular Ca2+ response elicited by AngII in bovine adrenal glomerulosa cells. After excluding multiple cellular mechanisms, we found that Ca2+ extrusion out of the cytosol through the plasma membrane NCX is negatively modulated by p38 MAPK and demonstrate that caffeine, a potent inhibitor of this regulatory pathway, maintains a high rate of calcium extrusion during hormonal stimulation.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials-- Antimycin, bovine serum albumin, Bu2cAMP, caffeine, chelerythrine chloride, creatine phosphokinase, DNase, EGTA, forskolin, Hepes, horseradish peroxidase-coupled anti-goat antibody, 3-isobutyl-1-methylxanthine, ionomycin, insulin/transferrin/selenium, LaCl3, ATP, nicardipine, oligomycin, oxalate, phosphocreatine disodium salt, phenylmethylsulfonyl fluoride, polyvinyl alcohol, pyruvate, rotenone, succinate, thapsigargin, and Triton X-100 were obtained from Sigma. D-glucose, EDTA, TEMED, and Tween 20 were purchased from Merck, and SB 203580 and PD 98059 were from Calbiochem. Ins(1,4,5)P3, 45Ca2+, and ECL hyperfilm were obtained from Amersham Biosciences; fura-2/AM, fluo-3/AM, fluo-4/AM, fura2 acid, and K4BAPTA were from Molecular Probes, Inc. (Eugene, OR); and Dulbecco's modified Eagle's medium, metyrapone, fetal calf serum, horse serum, and nystatin were from Invitrogen. Acrylamide, baicalein, and diltiazem were obtained from Fluka Chemie AG (Buchs, Switzerland). AngII was purchased from Bachem (Bubendorf, Switzerland), anti-rabbit antibody coupled to horseradish peroxidase enzyme was from CovalAb (Lyon, France); dispase was from Roche Molecular Biochemicals; garamycin was from ESSEX Chemie AG (Lucerne, Switzerland), glycine was from Axon Lab AG (Baden-Dättwil, Switzerland), M199 was from Biochrom KG (Berlin, Germany), metyrapone was from Aldrich, okadaic acid and PMA were from LC Laboratories (Woburn, MA), penicillin was from Hoechst-Pharma AG (Zürich, Switzerland), Percoll was from Amersham Biosciences, SDS was from Chemie Brunschwig, streptomycin was from Grünenthal (Stolberg, Germany), and Ultima Gold was from Packard Instrument Co. (Meriden, CT).

Isolation and Culture of Bovine Glomerulosa Cells-- Bovine adrenals were obtained from a local slaughterhouse, and glomerulosa cells were prepared by enzymatic dispersion with dispase and purified on a Percoll density gradient, as previously described in detail (22).

For primary culture, cells were transferred to antibiotic-containing Dulbecco's modified Eagle's medium, supplemented with insulin/transferrin/selenium (2 µg/ml insulin, 2 µg/ml transferrin, 2 ng/ml sodium selenite), 5 µM metyrapone, 2 mM glutamine, 6 units/ml nystatin, 2% (v/v) fetal calf serum, and 10% (v/v) horse serum. The cells were plated on 6- or 24-well culture plates (2 or 0.7 × 106 cells/well) and incubated overnight at 37 °C in 5% CO2. The next day, the medium was removed and replaced with serum-free Dulbecco's modified Eagle's medium.

Measurement of Calcium Concentration in Intact Cells-- Cytosolic calcium concentrations [Ca2+]c were determined with fluorescent probes in freshly prepared cell populations as previously described (8).

For this purpose, freshly purified cells were washed three times with 50 ml of Krebs-Ringer buffer and maintained in this medium for at least 60 min at 37 °C. Cells were then centrifuged, diluted at a concentration of 4 × 106 cells/ml, and incubated in the presence of 2 µM fura-2/AM, 5 µM fluo-3/AM, or 5 µM fluo-4/AM. The dye excess was then washed away, and cells were maintained in the same medium. Immediately before use, aliquots of 2 × 106 cells were washed and diluted in appropriate experimental medium.

The fluorescent signals (excitation at 340/380 nm and emission at 505 nm for fura-2, and excitation at 488 nm and emission at 540 nm for fluo-3 and fluo-4) were recorded with a Jasco (Hachioji City, Japan) CAF-110 fluorescence spectrometer. Calcium concentrations were calculated as described elsewhere (23), using a Kd value of 224 nM for fura-2 and 325 nM for fluo-3 and fluo-4.

Mathematical Analysis of Calcium Extrusion Rate-- Calcium traces, recorded in Ca2+-free, EGTA (0.2 mM)-supplemented Krebs-Ringer medium, were digitized at a frequency of 2 Hz and analyzed with a mathematical analysis program (Origin version 4.1). The decreasing phase of the response to AngII (Fig. 4) during the extrusion of calcium out of the cytosol was fitted over a 2-min period to a decreasing exponential function of the first order: y(t) = y0 + A × exp[-(t - t0)/t1/2], where y(t) is the value of [Ca2+]c as a function of time, y0 is the final calcium level reached after calcium extrusion from the cytosol, A is the amplitude of the calcium release peak, t0 is the beginning of the analysis interval (15 s after the calcium release peak), and t1/2 is the time constant corresponding to the half-life of calcium in the cytosol or more precisely the time taken by the cells to reach a cytosolic calcium level corresponding to 36.9% (1/e) of the initial concentration (at t0). This latter parameter (t1/2), determined after optimizing the fitting curve, reflects the rate of calcium extrusion out of the cytosol and was used to assess the action of various agents on calcium homeostasis.

Measurement of Calcium Release from the Organelles in Permeabilized Cells-- For measuring Ins(1,4,5)P3- and caffeine-induced calcium release from the organelles, glomerulosa cells were first permeabilized, as previously described (24). Freshly prepared cells were washed twice with M199 (2.66 g/liter modified Hanks' medium, 15 mM NaHCO3, 3.5 mM KCl, 120 mM NaCl) and once with Krebs-Ringer buffer. They were then incubated for 10 min in a Ca2+-free Krebs-Ringer solution supplemented with 50 µM EGTA. After incubation, cells were washed twice in 50 ml of permeabilization buffer (250 mM sucrose and 5 mM Hepes, pH 7.2). Cells were then permeabilized in a minimal volume by repeated (8-12 times) brief (100 µs) exposure to an intense electric field (1400 V/cm). Under these conditions, ~90% of treated cells were stained with trypan blue.

Before use, cells were washed and placed in an intracellular-like buffer (5 mM NaCl, 115 mM KCl, 5 mM NaHCO3, 1 mM KH2PO4, 0.05% (w/v) bovine serum albumin, and 20 mM Hepes, pH 7.2) at 37 °C under constant agitation. Cell autofluorescence was determined before adding free acid fura-2 (2 µM), Mg-ATP (2 mM), phosphocreatine disodium salt (10 mM), creatine phosphokinase (8 IU/ml), succinate (5 mM), pyruvate (5 mM), rotenone (0.1 µM), and oligomycin (1 µM) to initiate calcium incorporation into the organelles. After reaching a low steady state calcium level, tested agents were added directly into the ambient medium, and calcium fluctuations were followed by recording fura-2 fluorescent signal, as in intact cells. Calcium responses were calibrated by the addition of known amounts of CaCl2 into the medium after inhibition of calcium incorporation into the organelles with thapsigargin and ionomycin.

In experiments assessing 45Ca2+ incorporation into the organelles, permeabilized cells were maintained at 4 °C until adding the reaction buffer (100 mM KCl, 25 mM Hepes, 2 mM KH2PO4, 5 mM MgCl2, pH 7.4) containing 1 µCi/ml 45Ca2+, an ATP-regenerating system (3 mM MgATP, 10 mM phosphocreatine disodium salt, 8 IU/ml creatine phosphokinase), mitochondrial inhibitors (10 µM antimycin, 1 µg/ml oligomycin), 5 mM oxalate, and drugs to be tested. The free Ca2+ concentration in the medium was fixed at ~1 µM with 4.5 mM CaCl2 and 5 mM BAPTA. Cells (samples of 2-3 × 106) were immediately incubated for 15 min at 37 °C, and calcium uptake was stopped by the addition of 2 mM LaCl3 at 0 °C. Cells were then poured on Whatmann GF/B filters, and calcium excess was washed with 2 × 4 ml of washing buffer (250 mM sucrose, 40 mM NaCl, at 4 °C). Radioactivity retained on the filters was measured in a Packard 1900 TR beta  counter after adding 10 ml of UltimaGold.

Aldosterone Production-- Aldosterone production was determined in the medium of cells in primary culture. Two days after replacing culture medium by serum-free Dulbecco's modified Eagle's medium, plated cells were washed three times with Krebs-Ringer buffer and incubated for 30 min at 37 °C in the same solution containing different experimental drugs. After this first incubation, the medium was discarded and replaced by a fresh one of the same composition, and the cells were incubated for an additional 60-min period. At the end, the media were collected and centrifuged for 5 min at 1500 × g. The supernatants were frozen until aldosterone determination by direct radioimmunoassay, using a commercially available kit (Diagnostic Systems Laboratories, Webster, TX). Aldosterone production was expressed per mg of cell protein, itself measured in each dish with the Coomassie Blue method (Bio-Rad).

Determination of p38 MAPK Activation in Cultured Glomerulosa Cells-- The relative activity of the p38 MAPK was assessed by measuring the enzyme-phosphorylated form by immunoblotting. For this purpose, primary cultured cells were used 24-60 h after having been deprived of serum. After a 30-min preincubation at 37 °C with various agents tested, cells were stimulated for the indicated periods of time with AngII (100 nM). At the end of the stimulation period, cells were washed with cold phosphate buffer (137 mM NaCl, 1.47 mM KH2PO4, 10 mM Na2HPO4, 2.7 mM KCl, pH 7.2) and scraped into 75 µl of lysis buffer (50 mM Tris, 150 mM NaCl, 10% (v/v) glycerol, 1% (v/v) Triton X-100, 2 mM EDTA, 2 mM EGTA, 40 mM beta -glycerol phosphate, 50 mM NaF, 10 mM sodium pyrophosphate, 200 µM sodium orthovanadate, 1 mM phenylmethylsulfonyl fluoride, 100 nM okadaic acid, pH 7.4). The homogenates were centrifuged at 4 °C for 10 min at 50,000 × g, and supernatants collected for protein assay and Western blot analysis. Cell lysates (20 µg) were analyzed by SDS-PAGE (electrophoretic migration was performed during 40 min at 150 V and protein transfer during 1.5 h at 110 V). After transfer, the nitrocellulose membranes were incubated in a blocking buffer (50 mM Tris/HCl, 200 mM NaCl, 0.2% Tween 20, and 5% nonfat dried milk) for 1 h at room temperature. For total p38 MAPK detection, dried milk was replaced by polyvinyl alcohol (1%) in the blocking buffer. Membranes were then incubated for 2 h in the same buffer containing 1% nonfat dried milk or polyvinyl alcohol with polyclonal antibodies raised against phosphorylated p38 MAPK (New England BioLabs, Beverly, MA) or total p38 MAPK (Santa Cruz Biotechnology, Inc., Santa Cruz, CA). The membranes were washed with the same buffer without milk or polyvinyl alcohol and then incubated for 1 h with horseradish peroxidase-labeled goat anti-rabbit (CovalAb, Oullins, France) or rabbit anti-goat (Sigma) antibodies. After washing six times for 10 min, the immunoreactive bands were visualized by ECL detection reagent (Amersham Biosciences) and quantified by densitometry (Molecular Dynamics, Inc., Sunnyvale, CA).

Statistics-- Statistical significance of differences was assessed by the Student's t test. Probability values of p < 0.05 were considered as being statistically significant.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Effect of Caffeine on Calcium Signaling and Steroidogenesis in Adrenal Glomerulosa Cells-- Caffeine was initially used for investigating the presence and the role of various types of intracellular Ca2+ stores in the response of bovine adrenal glomerulosa cells to a challenge with AngII. Surprisingly, we observed that, when added during the sustained phase of the Ca2+ response to AngII, caffeine (2 mM) markedly reduced [Ca2+]c in freshly isolated glomerulosa cells (Fig. 1A). After inhibition by caffeine, nicardipine, a dihydropyridine antagonist, had only a slight effect on calcium levels. Interestingly, the same concentration of caffeine only marginally affected the calcium response to KCl (Fig. 1B) that remained sensitive to nicardipine. Moreover, no additional effect of caffeine was observed when maximal capacitative Ca2+ influx was concomitantly triggered by 200 nM thapsigargin (not shown). The analysis of the concentration dependence of the caffeine-induced inhibition of the Ca2+ signal (Fig. 1C) revealed that caffeine is much more efficient at reducing the response to AngII (IC50 = 1.3 mM) than the response to potassium (IC50 > 10 mM), suggesting that the drug interacts with a mechanism specifically generated by AngII.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 1.   Caffeine-induced inhibition of the calcium and steroidogenic responses to angiotensin II in bovine adrenal glomerulosa cells. Fura-2-loaded freshly isolated bovine glomerulosa cells were challenged, in the presence of extracellular calcium (1.2 mM), with 100 nM AngII (A) or 9 mM KCl (B) before being exposed to caffeine (caff) and nicardipine (nic). Calcium levels during the plateau phase (before the addition of caffeine) and after the inhibition of the signal with nicardipine were determined as described under "Experimental Procedures." The concentration-dependent inhibition of the sustained calcium signal by caffeine (C) was calculated as a percentage of the maximal inhibition induced by nicardipine from traces similar to those presented in A and B. Data are mean values ± S.E. from 13 experiments. D, bovine glomerulosa cells in primary culture were incubated for 1 h in the presence or absence of 100 nM AngII and with increasing concentrations of caffeine. Aldosterone was measured in the medium by direct radioimmunoassay and normalized to the amount of cell protein. Data (mean ± S.E. from nine independent experiments) are expressed as a percentage of the aldosterone induced by AngII in control cells (no caffeine), and that amounted to 106 ± 10 ng aldosterone/mg of prot/h. *, p < 0.0001.

The consequence of calcium inhibition by caffeine on the steroidogenic response to AngII was investigated in primary cultured bovine glomerulosa cells (Fig. 1D). Whereas basal aldosterone production appeared unaffected by caffeine, AngII-stimulated aldosterone was significantly reduced by 56 ± 5% in the presence of 10 mM caffeine. Aldosterone synthesis was not sensitive to lower concentrations of the drug, despite the marked decrease of the calcium signal observed previously, suggesting that AngII-induced steroidogenesis is also controlled by additional pathways, compensating for the partial decrease of calcium, or that the sensitivity of glomerulosa cells to caffeine is different in freshly prepared cells, used for calcium measurements, and in primary culture.

Lack of Caffeine Effect on Calcium Release from Intracellular Stores-- To determine the site and mechanism of caffeine action on AngII-induced calcium signaling, we first measured whether caffeine affects intracellular calcium pools. Preliminary experiments performed with intact cells showed that caffeine (10 mM) had no effect on [Ca2+]c in unstimulated cells and did not significantly reduce the amplitude of the transient [Ca2+]c response to AngII (data not shown). Additional experiments directly assessed the action of caffeine on Ins(1,4,5)P3-sensitive and -insensitive stores in permeabilized glomerulosa cells (Fig. 2). Whereas the addition of micromolar concentrations of Ins(1,4,5)P3 induced an immediate and transient release of calcium into the ambient medium, low millimolar concentrations of caffeine were inefficient and did not prevent a subsequent response to Ins(1,4,5)P3 (Fig. 2A). The integrity of the pools was finally tested by sequential addition of 400 nM thapsigargin, an inhibitor of intracellular Ca2+-ATPases (SERCA), and 2 µM ionomycin, a Ca2+ ionophore. The lack of caffeine-sensitive intracellular Ca2+ pools in bovine glomerulosa cells was confirmed by adding increasing concentrations of ryanodine, a drug acting on the same type of Ca2+ stores as caffeine and which could not induce calcium release in permeabilized (Fig. 2B) as well as in intact glomerulosa cells (data not shown). Moreover, the presence of 10 mM caffeine in the medium did not affect the functional response to Ins(1,4,5)P3 (Fig. 2C). Indeed, EC50 values determined in the absence and in the presence of 10 mM caffeine (0.59 and 0.45 µM, respectively) were not significantly different, a finding in agreement with the previous observation that the peak response to AngII was unaffected by caffeine in intact cells.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 2.   Intracellular calcium stores are insensitive to caffeine in bovine glomerulosa cells. Freshly prepared glomerulosa cells were permeabilized by using high voltage electric field discharges, as described under "Experimental Procedures," and ambient calcium concentration fluctuations were recorded at 37 °C with free acid fura-2. After the addition of ATP and accumulation of ambient calcium into the organelles (not shown), cells were exposed to various concentrations of Ins(1,4,5)P3 (IP3), caffeine (caff), or ryanodine. At the end of each trace, Ca2+ was totally released from the organelle by the successive addition of 400 nM thapsigargin (thapsi) and 2 µM ionomycin (iono), and calcium responses were normalized by the addition of known amounts of CaCl2 in the medium (not shown).

Caffeine Action Is Not Mediated by cAMP-- To exclude the possibility that caffeine could modulate calcium levels through an inhibition of the phosphodiesterases and a subsequent elevation of cAMP concentration, we measured the effect of various agents affecting cAMP on Ca2+ homeostasis. As shown in Fig. 3, forskolin (25 µM), a pharmacological activator of adenylyl cyclases, was unable to reduce the AngII-induced [Ca2+]c plateau and did not prevent caffeine action. The efficacy of forskolin was indirectly assessed in parallel experiments by measuring aldosterone secretion (Fig. 3, inset). At the same concentration (25 µM), forskolin appeared as potent as AngII (100 nM) to stimulate steroidogenesis, most probably through activation of the cAMP pathway, which, like calcium, is a well recognized modulator of aldosterone biosynthesis. The same results have been obtained with either 3-isobutyl-1-methylxanthine (100 µM), an inhibitor of the cAMP phosphodiesterase, or the cell-permeant analog Bu2cAMP (1 mM). Thus, it appears that caffeine action on [Ca2+]c is not mediated by a change in cAMP levels.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 3.   Caffeine-induced inhibition of the calcium signal does not involve the cAMP pathway. Intact fura-2-loaded cells were stimulated with 100 nM AngII, as in Fig. 1A, but 25 µM forskolin was added before the inhibition by caffeine (caff). This trace is representative of five independent experiments giving similar results. Inset, aldosterone production by cells exposed to 25 µM forskolin was determined as in Fig. 1D and compared with aldosterone secreted by control or AngII-stimulated cells. nic, nicardipine.

Caffeine Accelerates Calcium Extrusion Out of the Cytosol-- A reduction of [Ca2+]c, as illustrated in Fig. 1A, can result either from a decrease of calcium influx into the cytosol or from an activation of calcium extrusion. This second possibility was tested by exposing fura-2-loaded cells to AngII in the absence of extracellular calcium. We observed, after a transient response exclusively due to calcium release from intracellular stores, a dramatic acceleration of calcium lowering back to basal levels in the presence of 10 mM caffeine as compared with control cells (Fig. 4). A systematic analysis of the rate of calcium extrusion was performed by fitting the decreasing phase of the calcium response to a single exponential function and by comparing the time constants (t1/2). Caffeine significantly reduced calcium half-life in the cytosol, decreasing t1/2 from 0.67 ± 0.04 min in control cells to 0.35 ± 0.03 min (Fig. 4, inset).


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 4.   Caffeine increases calcium extrusion out of the cytosol after AngII-induced release. Intact fura-2-loaded cells were stimulated with 100 nM AngII in a Ca2+-free medium (containing 0.2 mM EGTA), supplemented or not with 10 mM caffeine (caff). The rate of Ca2+ extrusion out of the cytosol was determined by fitting the decreasing phase of the calcium response, occurring during the 2-min period following the calcium release peak, to a single exponential function of the form: y(t) = y0 + Ae(-(t - t0)/t1/2), with the time constant t1/2 representing the "half-life" of the stimulated calcium in the cytosol. Inset, mean t1/2 values ± S.E. were determined from the analysis of 50 independent traces obtained with control and caffeine-treated cells. Similar experiments were then performed after inhibiting SERCA pumps with 2 µM thapsigargin (n = 10). *, p < 0.05; ***, p < 0.005.

The role of SERCA pumps in calcium extrusion and its possible activation by caffeine was then investigated by repeating the same experiments in the presence of 2 µM thapsigargin, added immediately before AngII. The presence of the latter drug did not significantly affect the kinetics of calcium extrusion and did not prevent caffeine action, suggesting that the activity of SERCA pumps is not limiting in this process.

This result was confirmed by the observation that the ATP-dependent 45Ca2+ uptake into the stores of permeabilized cells (152 ± 11 nmol of Ca2+/mg of protein/15 min) was not increased by 10 mM caffeine (128 ± 8 nmol/mg of protein/15 min, n = 4). Similar results were obtained in the presence of 100 nM AngII (123 ± 13 and 105 ± 19 nmol/mg of protein/15 min in control cells and in caffeine-treated cells, respectively).

Involvement of the Na+/Ca2+ Exchanger in Ca2+ Extrusion-- In order to test the role of the NCX in Ca2+ extrusion from the cytosol, we pretreated the cells with 50 µM diltiazem, a known inhibitor of this protein, before inducing calcium release with AngII in the absence of extracellular Ca2+. Under these conditions, we observed a marked decrease of the rate of calcium extrusion, the t1/2 value increasing from 0.7 to 2.7 min (Fig. 5, Ctrl). This result suggests that the activity of the NCX controls the rate of Ca2+ extrusion. It is noteworthy that an inhibition by diltiazem of the voltage-operated Ca2+ channels is unlikely to be responsible for this effect on Ca2+ extrusion, because Ca2+ is absent from the medium and because the addition of nifedipine, another blocker of these channels, did not change the kinetics of calcium extrusion (data not shown). Diltiazem treatment did not affect the size of the peak due to the Ca2+ release phase. Moreover, after inhibition of the NCX with diltiazem, caffeine was not any more efficient, indicating that it probably interferes with this pathway of Ca2+ extrusion.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 5.   Diltiazem decreases calcium extrusion and prevents caffeine action. Intact cells were exposed to 50 µM diltiazem, in a Ca2+-free medium, before being stimulated with 100 nM AngII, in the presence or in the absence of 10 mM caffeine (caff), and the rate of calcium extrusion was assessed as described in the legend to Fig. 4. Inset, mean t1/2 values ± S.E. are compared with those obtained with untreated cells. ***, p < 0.005; n.s., not significantly different.

The role of the NCX in bringing Ca2+ back to basal levels after release from the stores was confirmed 1) by decreasing the concentration of extracellular Na+ or 2) by depolarizing the cells with KCl. Indeed, when [Na+]o was reduced from 140 down to 15 mM, Ca2+ extrusion after release by AngII was markedly impaired (Fig. 6, inset). Actually, at low [Na+]o, cells were unable to bring [Ca2+]c back to basal levels, even in the absence of extracellular Ca2+, a fact probably reflecting the establishment of a new steady state and impairing analysis of kinetics. We therefore calculated the ratio between the [Ca2+]c plateau measured after 3.5 min and the [Ca2+]c peak during the release phase as an inverse index for the efficacy of calcium extrusion. The value of this ratio significantly increased from 17 to 33% when [Na+]o was reduced from 140 to 65 mM and even more at lower [Na+]o (Fig. 6). The osmolarity of the medium was maintained at 325 mosM/liter in these experiments by adding glucose. The reduced ability of the cells to extrude Ca2+ in low [Na+]o strongly supports a crucial role for the NCX in this process.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 6.   Effect of the extracellular sodium concentration on the cell ability to extrude calcium. Intact fura-2-loaded glomerulosa cells were stimulated with 100 nM AngII in calcium-free media containing various concentrations of sodium. In each condition, the osmolality of the medium was maintained at 325 mosM by adjunction of glucose. A plateau calcium level (Delta  plateau) was measured 3.5 min after the calcium release peak, and its value was expressed as a percentage of the peak height (Delta  peak). For each sodium concentration, 5-17 traces were analyzed, and data were averaged. Control medium contained 140 mM sodium. *** and ****, significantly different from control with p < 0.005 and 0.001, respectively. Inset, example of a calcium response recorded in a medium containing 15 mM sodium and illustrating the method for determining the Delta  peak and Delta  plateau values.

Because the NCX exchanges three Na+ for one Ca2+, it is electrogenic, and its activity therefore decreases upon plasma membrane depolarization. Indeed, we observed that upon the addition of 15 mM potassium, which depolarizes the cells from their resting potential, -80 mV, to approximately -50 mV, the rate of calcium extrusion was significantly reduced (Table I) but remained sensitive to caffeine.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Effect of potassium and modulators of protein kinase C on the rate of calcium extrusion
Bovine glomerulosa cells were incubated a few minutes in a calcium-free medium in the presence of various agents (18 mM KCl, 500 nM PMA, 2 µM CGP 41, 1-10 µM chelerythrine chloride, or 0.2-1 µM calphostin C) and with or without 10 mM caffeine before being stimulated with 100 nM AngII. Cytosolic calcium responses were recorded with fura-2 or, in the case of chelerythrine, with fluo-3 or fluo-4. The rate of calcium extrusion was then determined as described in the legend to Fig. 4. Values obtained with untreated (control) cells are indicated for comparison. Data are the mean ± S.E. from 5-37 determinations. NS, not significantly different; ND, not determined.

Mechanism of Angiotensin II Action on the Sodium/Calcium Exchanger-- Because caffeine accelerates Ca2+ extrusion more efficiently upon stimulation with AngII, we hypothesized that the hormone inhibits the exchanger and that the drug interferes with this regulatory pathway. We therefore dissected the possible mechanisms of action employed by AngII to modulate NCX activity.

PKC is known to be activated upon glomerulosa cell stimulation by AngII but not by extracellular potassium (25). Therefore, this pathway appeared first as a good candidate for playing a role in AngII action on NCX. Indeed, we found that a pharmacological activation of PKC with the phorbol ester PMA (500 nM) markedly slowed the Ca2+ decrease phase after AngII (Table I), whereas, under these conditions, the mechanism remained sensitive to caffeine, which probably acts downstream of PKC. However, the results obtained with a series of PKC inhibitors, used in order to mimic caffeine action, were not entirely consistent with a major role of PKC in the regulation of the NCX activity. While the PKC inhibitor CGP41 (26), as expected, significantly accelerated Ca2+ extrusion, other PKC inhibitors such as chelerythrine chloride (27) and calphostin C (28) had no significant effect (Table I).

These results suggest that PKC could participate in the negative regulation of the exchanger, but it appears not to be absolutely required, and other mechanisms probably coexist. We therefore investigated alternative pathways activated by AngII and modulated by PKC, such as the 12-lipoxygenase and the p42/44 and p38 mitogen-activated protein kinases.

A first clue in favor of the involvement of p38 MAPK was given by the observation that Ca2+ extrusion is impaired when cells are incubated in hypo-osmotic medium, a condition known to regulate, positively or negatively, p38 MAPK activity in various cell types (29-32). Indeed, reducing the osmolarity of the medium from a control value of 325 down to 225 mosM/liter, significantly increased the steady state Ca2+ plateau established after Ca2+ release with AngII (Table II). In these experiments, [Na+]o was maintained constant at 65 mM, and the osmolarity was adjusted with various glucose concentrations. In contrast, increasing the medium osmolarity to 425 mosM/liter had no notable effect on Ca2+ extrusion.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Effect of medium osmolarity on the rate of calcium extrusion
Bovine glomerulosa cells were stimulated with 100 nM AngII in calcium-free media containing a fixed concentration of Na+ (65 mM) and with an osmolarity adjusted to various values with different concentrations of glucose. Calcium responses were determined with fura-2, and the ratio between the plateau (reached after 3.5 min) and the peak was analyzed as described in the legend to Fig. 6. NS, not significantly different.

We then directly tested the involvement of MAPKs by using specific inhibitors. While the PD 98059 compound, selective for the p42/44 MAPK (33), had no significant effect on the rate of Ca2+ extrusion (Table III) and did not prevent the caffeine-induced acceleration of Ca2+ removal, inhibition of the p38 MAPK with SB 203580 (34) resulted in a decrease of the t1/2 value from 0.72 ± 0.04 to 0.51 ± 0.02 min (p < 0.001, n = 17). Most interestingly, in the presence of this inhibitor, caffeine action was not any more significant, suggesting that caffeine and SB 203580 act on a common target.

                              
View this table:
[in this window]
[in a new window]
 
Table III
Effect of lipoxygenase and MAPK inhibition on calcium extrusion
Bovine glomerulosa cells were incubated for 5-30 min in the presence of various agents (50 µM PD 98059, an inhibitor of p42/44 MAPK, 10 µM SB 203580, an inhibitor of p38 MAPK, or 10 µM baicalein, an inhibitor of lipoxygenases) and with or without 10 mM caffeine before being stimulated, in the absence of extracellular calcium, with 100 nM AngII. Cytosolic calcium responses were recorded with fluo-3 (PD and SB compounds) or fura-2 (baicalein). The rate of calcium extrusion was then determined as described in the legend to Fig. 4. Values obtained with untreated (control) cells in the same experiments are also indicated for comparison. Data are the mean ± S.E. from 5-17 determinations. NS, not significantly different.

Similarly, in Ca2+-containing medium, SB 203580 (20 µM) induced a rapid decrease of the AngII-induced Ca2+ plateau levels, as previously observed in response to caffeine (data not shown). Moreover, when SB was added 15-30 min before AngII, the sustained Ca2+ phase (measured 3 min after the hormone addition) was reduced from 24 ± 7 (in control cells) down to 6 ± 2 nM (mean ± S.E., n = 3). In the presence of SB, the caffeine (3 mM) addition had no more effect on [Ca2+]c levels, once again strongly suggesting the existence of a common mechanism for caffeine and SB 203580 action.

In contrast, when both capacitative influx and Ca2+ entry through voltage-operated Ca2+ channels were triggered in the absence of AngII (by the simultaneous addition of 200 nM thapsigargin and 9 mM KCl), no effect of SB was observed on [Ca2+]c levels, therefore excluding a direct effect of this drug on Ca2+ channel activity.

The lipoxygenases have been shown to be activated by AngII in adrenal glomerulosa cells (18), and more specifically the product 12-HETE appeared to be required for an optimal Ca2+ response (13). In addition, p38 MAPK has been proposed to be regulated by the lipoxygenase product 12-HETE (14). We therefore tested a possible role of this pathway on the rate of Ca2+ extrusion. As shown in Table III, the inhibitor of the 12-lipoxygenase, baicalein, also accelerated Ca2+ decrease. However, baicalein did not reduce caffeine action, which presumably acts downstream of lipoxygenase.

Finally, the time course of p38 MAPK activation by AngII and its inhibition by caffeine and SB 203580 have been determined by measuring the phosphorylated form of the enzyme with a specific antibody (Fig. 7). The hormone increased the active form of the kinase by 22-fold within 2 min, without modifying the amount of total p38 MAPK (Fig. 7A). The time course analysis of this activation was transient, with a maximal response between 2 and 5 min and a decrease to basal values after 15 min (Fig. 7B).


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 7.   Inhibition by caffeine of the AngII-stimulated p38 MAPK. The activation of p38 MAPK upon stimulation of glomerulosa cells with AngII (100 nM) was determined in the presence of various agents, as described under "Experimental Procedures." A, phosphorylated (activated) and total p38 MAPK Western blot analysis in cells stimulated with AngII for various periods. B, kinetics of p38 activation by AngII. The amount of phosphorylated p38 MAPK present at different times was determined by densitometry of the membrane shown in A and expressed as -fold increase of the control value (n = 2). C, kinetics of caffeine- and SB 203580-induced p38 MAPK inhibition. Activity of p38 MAPK was determined after 4-min stimulation with 100 nM AngII and in the presence of 10 mM caffeine or 10 µM SB 203580 for the indicated periods of time. Relative activity was expressed as a percentage of the activity determined in control cells, stimulated in the absence of inhibitors. The average basal (unstimulated) p38 activity in these experiments is indicated by the dotted line. Data are the mean ± S.E. from 3-5 independent experiments. D, activation of p38 MAPK upon hypo-osmotic shock. Relative p38 MAPK activity was determined in the absence (basal) or presence of AngII (100 nM) in the same media as those described in the legend of Table II. Results are the mean from two independent experiments.

The ability of caffeine to prevent p38 MAPK activation was compared with that of SB 203580 by adding the drugs in the medium at different times before or during a 4-min stimulation with AngII (Fig. 7C). The addition of 10 µM SB into the medium resulted in a rapid reduction of p38 MAPK phosphorylation levels by ~50% within 30 s. The inhibitory effect of SB tended to diminish upon prolonged (> 20 min) treatment, but inhibition was further reinforced (by 15%) when increasing the concentration of the drug up to 100 µM (not shown).

Although slightly slower for inducing its effect, caffeine (10 mM), at 5 min, was as efficient as the SB compound (10 µM) at reducing AngII-induced p38 activation, and no additional effect was observed when combining optimal concentrations of caffeine and SB 203580 (not shown).

Moreover, in two independent experiments, baicalein (10 µM) also slightly reduced p38 activation (by 20%), reinforcing the hypothesis that the 12-HETE products could act as physiological activators of the kinase.

We have also determined the effect of medium osmolarity on p38 MAPK activity. As illustrated in Fig. 7D, increasing medium osmolarity from 225 up to 425 mosM/liter led to a more than 50% reduction of basal p38 activity. Although the activation by AngII was particularly weak under these conditions (at low extracellular sodium concentration), the general tendency to obtain a higher p38 activity in hypo-osmotic medium was maintained in the presence of the hormone.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In the present study, we have unraveled a new cellular pathway involved in the regulation of calcium homeostasis upon stimulation of adrenal glomerulosa cells by AngII. While the presence of this pathway was initially suggested by its sensitivity to caffeine, a largely nonspecific drug, further investigation showed the involvement of well characterized effectors, such as PKC, lipoxygenase, p38 MAPK, and the NCX.

Caffeine action on the calcium signal elicited by AngII was robust and reproducible enough to use this effect as a sort of marker for analyzing the mechanisms involved in the hormone action. Moreover, caffeine acted much more efficiently on the Ca2+ response to AngII than on the response to extracellular potassium (Fig. 1C) or the Ca2+ ionophore, ionomycin (data not shown), suggesting that the drug interfered with a pathway specifically induced by AngII and not simply activated by an elevation of the cytosolic calcium concentration. Finally, caffeine-induced inhibition of the Ca2+ response to the hormone was translated in a concomitant reduction of aldosterone production, highlighting the physiological relevance of this observation.

Caffeine is known for its multiple actions on various targets involved in cell signaling. In this context, we first showed that caffeine does not influence Ca2+ through modulation of cAMP levels or Ins(1,4,5)P3-induced Ca2+ release. Indeed, a cross-talk between cAMP and the Ca2+ messenger system has been described in many cell types with either potentiating or antagonist properties. For example, by inhibiting the cAMP-specific phosphodiesterases (35) caffeine could induce an elevation of basal cytosolic cAMP concentration and subsequently activate phospholamban-regulated Ca2+/Mg2+-ATPases (36). This mechanism could have been responsible for the decrease of [Ca2+]c observed upon the addition of caffeine. To exclude this possibility, we have verified that neither forskolin, a potent activator of adenylyl cyclases; 3-isobutyl-1-methylxanthine, an inhibitor of the phosphodiesterases; nor a cell-permeant analog of cAMP, Bu2cAMP, could mimic or prevent caffeine action.

Similarly, caffeine has been proposed to directly affect Ca2+ homeostasis, positively or negatively, through many different mechanisms. The activation of Ca2+ release from intracellular stores through stimulation of ryanodine-sensitive intracellular Ca2+ channels has been described in muscle and nonmuscle cells for a very long time (37). However, opposite effects of the drug have been also reported. In Xenopus oocytes, caffeine has been shown to inhibit Ca2+ mobilization by preventing Ins(1,4,5)P3 action (38). Similar results have been obtained with microsomes from rat or dog cerebellum (39, 40). Caffeine has also been reported to decrease phospholipase C activation by muscarinic receptor in guinea pig smooth muscle (41) and to reduce the activity of voltage-gated Ca2+ channels in rabbit artery (42) and GH3 cells (43).

In our study, all of these possible modes of caffeine action were excluded by demonstrating that 1) there is no caffeine (or ryanodine)-sensitive stores in permeabilized bovine glomerulosa cells, 2) the presence of caffeine does not affect the response to Ins(1,4,5)P3, and finally 3) the amplitude of the transient [Ca2+]c response was not affected by caffeine.

Whereas, at this stage of our investigations, the molecular mechanisms involved in caffeine action remained unclear, the ultimate target of the drug (i.e. the Ca2+ transporter affected by the treatment) was also unknown. Because a change in [Ca2+]c can result from a modification in the rate of either Ca2+ influx into or of Ca2+ extrusion from the cytosol, we decided to simplify the system by reducing the number of Ca2+ compartments. Indeed, by measuring caffeine action in the absence of extracellular calcium, we excluded a component of the response due to Ca2+ influx from outside.

Under these new experimental conditions, caffeine appeared as an activator of Ca2+ extrusion from the cytosol, and various possible effectors involved in this transport were tested. Thapsigargin, a specific inhibitor of the SERCA pumps (44), did not significantly reduce the rate of Ca2+ extrusion after release by AngII and did not prevent caffeine-induced acceleration of this process. This finding strongly suggests that Ca2+ reuptake into the organelles is not the most efficient mechanism in bovine glomerulosa cells to bring [Ca2+]c back to basal levels, at least during a large elevation of [Ca2+]c such as that elicited by an optimal concentration of AngII, and that SERCAs are probably not the target of caffeine action. This assumption is also supported by the observation that 45Ca2+ uptake into the organelles of permeabilized glomerulosa cells is not affected by caffeine.

Another relevant candidate for controlling Ca2+ removal from the cytosol was the diltiazem-sensitive plasma membrane sodium/calcium exchanger. Although diltiazem does not only affect NCX, in the absence of extracellular Ca2+, the contribution of diltiazem-sensitive Ca2+ channels is negligible. Actually, the rate of Ca2+ extrusion was profoundly affected after inhibition of the exchanger, not only pharmacologically with diltiazem but also after reducing the driving force for this transport either by decreasing the extracellular Na+ concentration or by depolarizing the cells with potassium. Altogether, these observations indicate that the NCX plays a crucial role in extruding cytosolic Ca2+ and that its activity is rate-limiting. Moreover, this mechanism is probably in great part responsible for the increase in cytosolic Na+ concentration we previously observed in bovine glomerulosa cells upon stimulation with AngII (5). More importantly, after NCX inhibition, caffeine was unable to accelerate Ca2+ extrusion. Thus, we propose that the NCX is this ultimate effector affected by caffeine.

The activity of this exchanger is directly dependent on the levels of [Ca2+]c, but caffeine affects more efficiently the response to AngII than the response to extracellular potassium. We therefore postulated that caffeine does not act directly on the exchanger but on a regulatory step specifically elicited by AngII. In fact, the acceleration of Ca2+ extrusion by caffeine is believed to result from the relief of an inhibitory signal on the NCX induced by the hormone itself. Indeed, calcium signaling upon stimulation by AngII results from the opening of various Ca2+ channels that will lead to an increase in [Ca2+]c. If no other mechanism is involved by the hormone, this Ca2+ elevation will trigger extrusion mechanisms, like Ca2+ ATPases and the NCX, that will immediately oppose this Ca2+ increase. The consequence will be the creation of futile cycles of Ca2+ across the membrane and therefore a waste of energy for the cell. In contrast, if the hormone simultaneously stimulates Ca2+ entry and reduces Ca2+ extrusion, the Ca2+ response is optimized.

Therefore, we investigated which pathway, sensitive to caffeine and elicited by the hormone, could be responsible for the NCX inhibition. In this regard, the involvement of PKC was strongly suggested by the negative effect of PMA as well as the positive action of the PKC inhibitor, CGP41, on the rate of Ca2+ extrusion. However, two other pharmacological antagonists of the enzyme, chelerythrine chloride and calphostin C, had no effect on this parameter. This apparent contradiction could be explained by the fact that PKC could act as a simple modulator of a signaling step that is directly activated by AngII, independently of this enzyme. This step could be mediated, for example, by a phospholipase A2 or a diacylglycerol lipase, leading to the formation of arachidonic acid. Alternatively, only specific isoforms of PKC, with various sensitivities to pharmacological inhibitors, could be involved in this modulation. In this context, it is noteworthy that, in rat glomerulosa cells, the lipoxygenase products 12- and 15-HETE have been shown to specifically activate PKC-epsilon , whereas AngII stimulates both the alpha  and epsilon  PKC isoforms (45).

The implication of the p38 MAPK in the modulation of the NCX activity was first suggested by the observation that a low osmolarity in the medium reduces, in an Na+-independent manner, the ability of the cells to extrude calcium (Table II). Indeed, this kinase has been shown to be involved in the response to various cellular stresses, including osmotic shock (14). We therefore verified that AngII effectively activates p38 MAPK, with kinetics in agreement with an effect on the early Ca2+ response to the hormone. A more than 10-fold increase in the activity of p38 within 1 min is perfectly compatible with a role of this kinase in the regulation of Ca2+ extrusion occurring immediately after the Ca2+ release phase induced by AngII. Moreover, the presence of a specific inhibitor of p38 MAPK, SB 203580, that reduces the AngII-induced activation of the kinase by 50% within 30 s, significantly accelerated Ca2+ extrusion (Table III), mimicking and preventing caffeine action. These results suggest that the SB compound and caffeine could act on the same target, a hypothesis supported by the fact that caffeine prevents the activation of p38 by AngII as efficiently as SB, although with slightly slower kinetics.

Although p38 MAPK is classically activated in most of the cell types by an increase in medium osmolarity (hyperosmotic shock), the opposite is apparently happening in bovine glomerulosa cells, as already described in renal epithelial A6 cells by Niisato et al. (29). The reason for this discrepancy between cell types is still unclear, but our results are consistent with the different rates of Ca2+ extrusion we have measured in the present study in hypo- and hyperosmotic conditions and with the observation by Makara et al. (46) that lowering osmolarity leads to increased potassium-induced calcium response and aldosterone production in rat adrenal glomerulosa cells.

From a teleological point of view, the inhibition of the NCX by a kinase activated upon cell exposure to a low osmolar medium is certainly an advantage for these cells. Indeed, the stoichiometry of the exchanger allows the entry of 3 mol of Na+ when extruding 1 mol of Ca2+, and this activity could be harmful for the cell in a situation where it should rather expel osmolites to the exterior.

In contrast to SB 203580, the inhibitor specifically blocking the p42/44 MAPK, PD 98059, did not affect the kinetics of Ca2+ extrusion and did not prevent caffeine action, showing the specificity of the pathway involved in the control of the NCX.

In summary, our hypothesis that caffeine reduces AngII-evoked Ca2+ signaling through an inhibition of p38 MAPK is strongly supported by the fact that SB 203580 mimics caffeine action on Ca2+ responses, that caffeine mimics the SB inhibitory action on p38, and, most importantly, that none of these caffeine and SB actions are additive when combining the two drugs.

The molecular link between p38 MAPK and NCX activity remains to be demonstrated. The large increase in cytosolic sodium observed upon bovine glomerulosa cell challenging with AngII (5), if not secondary to NCX activation, could be responsible for reducing the activity of this exchanger. In this regard, Kusuhara et al. (47) have reported a modulation of the Na+/H+ exchanger type 1 by MAPKs in vascular smooth muscle cells. However, whereas Na+/H+ exchanger type 1 was activated by p42/p44 MAPK, leading to an increase of intracellular Na+, it was inhibited upon stimulation of p38 MAPK. It therefore appears that a major modulation of the NCX by AngII through MAPK-dependent increase in sodium influx is unlikely in bovine glomerulosa cells.

Finally, because the 12-HETE compound has been reported to activate p38 MAPK in H295R cells (21), we tested whether inhibition of lipoxygenases with baicalein interferes with Ca2+ homeostasis. The acceleration of Ca2+ extrusion by baicalein (Table III) speaks in favor of the involvement of lipoxygenase products in the modulation of the exchanger. Interestingly, caffeine remained efficient after lipoxygenase inhibition, probably because caffeine acts downstream of baicalein, a suggestion supported by the fact that the latter slightly reduces the p38 MAPK activity.

In conclusion, our data strongly suggest that AngII, in parallel to the activation of Ca2+ entry into adrenal glomerulosa cells, also reduces Ca2+ extrusion from the cytosol through the Na+/Ca2+ exchanger in order to prevent futile cycling of Ca2+ across the plasma membrane. This modulation of the exchanger activity involves lipoxygenases, the p38 MAPK, and possibly some specific isoforms of PKC. The sensitivity of p38 MAPK inhibition to caffeine explains the action of this drug on the Ca2+ homeostasis previously observed upon stimulation with AngII. Because of the ubiquity of this mechanism, possibly resulting from an ancestral mean of the cells to protect themselves against osmotic shocks, similar pathways are probably present in a variety of cell types and could be elicited by various Ca2+-mobilizing hormones.

    ACKNOWLEDGEMENTS

We are particularly grateful to Prof. A. M. Capponi for useful discussions and to C. Gerber-Wicht for excellent technical assistance.

    FOOTNOTES

* This work was supported by Swiss National Science Foundation Grant 32-58948.99 and by a grant from the Jubiläumsstiftung der Schweizerischen Lebensversicherungs-und Rentenanstalt für Volksgesundheit und medizinische Forschung.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Division of Endocrinology and Diabetology, University Hospital, 24 rue Micheli-du-Crest, CH-1211 Geneva 14, Switzerland. Tel.: 41-22-3729320; Fax: 41-22-3729329; E-mail: rossier@cmu.unige.ch.

Published, JBC Papers in Press, April 30, 2002, DOI 10.1074/jbc.M110947200

    ABBREVIATIONS

The abbreviations used are: AngII, angiotensin II; Bu2cAMP, dibutiryl cyclic AMP; TEMED, N,N,N',N'-tetraethylmethylene diamine; Ins(1, 4,5)P3, inositol 1,4,5-trisphosphate; BAPTA, 1,2-bis-(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid; HETE, hydroxyeicosatetraenoic acid; NCX, Na+/Ca2+ exchanger; PKC, protein kinase C; MAPK, mitogen-activated protein kinase; MEK, mitogen-activated protein kinase/extracellular signal-regulated kinase kinase; ERK, extracellular signal-regulated kinase; PMA, phorbol 12-myristate 13-acetate.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Barrett, P. Q., Bollag, W. B., Isales, C. M., McCarthy, R. T., and Rasmussen, H. (1989) Endocr. Rev. 10, 496-518[Abstract/Free Full Text]
2. Spät, A., Enyedi, P., Hajnoczky, G., and Hunyady, L. (1991) Exp. Physiol. 76, 859-885[Medline] [Order article via Infotrieve]
3. Capponi, A. M., Python, C. P., and Rossier, M. F. (1994) Endocrine 2, 579-586
4. Barrett, P. Q., Isales, C. M., Bollag, W. B., and McCarthy, R. T. (1991) Am. J. Physiol. 261, F706-F719[Medline] [Order article via Infotrieve]
5. Van der Bent, V., Demole, C., Johnson, E. I. M., Rossier, M. F., Python, C. P., Vallotton, M. B., and Capponi, A. M. (1993) Endocrinology 133, 1213-1220[Abstract/Free Full Text]
6. Kojima, I., Kojima, K., Kreutter, D., and Rasmussen, H. (1984) J. Biol. Chem. 259, 14448-14457[Abstract/Free Full Text]
7. Kojima, I., Shibata, H., and Ogata, E. (1986) Biochem. J. 237, 253-258[Medline] [Order article via Infotrieve]
8. Rossier, M. F., Aptel, H. B. C., Python, C. P., Burnay, M. M., Vallotton, M. B., and Capponi, A. M. (1995) J. Biol. Chem. 270, 15137-15142[Abstract/Free Full Text]
9. Kojima, I., Kojima, K., and Rasmussen, H. (1985) Endocrinology 117, 1057-1066[Abstract/Free Full Text]
10. Natarajan, R., Stern, N., and Nadler, J. (1988) Biochem. Biophys. Res. Commun. 156, 717-724[CrossRef][Medline] [Order article via Infotrieve]
11. Natarajan, R., Stern, N., Hsueh, W., Do, Y., and Nadler, J. (1988) J. Clin. Endocrinol. Metab. 67, 584-591[Abstract/Free Full Text]
12. Natarajan, R., Dunn, W. D., Stern, N., and Nadler, J. (1990) Mol. Cell. Endocrinol. 72, 73-80[CrossRef][Medline] [Order article via Infotrieve]
13. Stern, N., Yanagawa, N., Saito, F., Hori, M., Natarajan, R., Nadler, J., and Tuck, M. (1993) Endocrinology 133, 843-847[Abstract/Free Full Text]
14. Widmann, C., Gibson, S., Jarpe, M. B., and Johnson, G. L. (1999) Physiol. Rev. 79, 143-180[Abstract/Free Full Text]
15. Chabre, O., Cornillon, F., Bottari, S. P., Chambaz, E. M., and Vilgrain, I. (1995) Endocrinology 136, 956-964[Abstract]
16. Tian, Y., Smith, R. D., Balla, T., and Catt, K. J. (1998) Endocrinology 139, 1801-1809[Abstract/Free Full Text]
17. McNeill, H., Puddefoot, J. R., and Vinson, G. P. (1998) Endocr. Res. 24, 373-380[Medline] [Order article via Infotrieve]
18. Natarajan, R., Gonzales, N., Hornsby, P. J., and Nadler, J. (1992) Endocrinology 131, 1174-1180[Abstract/Free Full Text]
19. Smith, R. D., Baukal, A. J., Dent, P., and Catt, K. J. (1999) Endocrinology 140, 1385-1391[Abstract/Free Full Text]
20. Natarajan, R., Scott, S., Bai, W., Yerneni, K. K., and Nadler, J. (1999) Hypertension 33, 378-384[Abstract/Free Full Text]
21. Yang, D. C., Nadler, J., Lanting, L., and Natarajan, R. (1999) 81st Annual Meeting of the Endocrine Society Abstracts , p. 361, Endocrine Society Press, Bethesda, MD
22. Rossier, M. F., Python, C. P., Capponi, A. M., Schlegel, W., Kwan, C. Y., and Vallotton, M. B (1993) Endocrinology 132, 1035-1043[Abstract/Free Full Text]
23. Grynkiewicz, G., Poenie, M., and Tsien, R. Y. (1985) J. Biol. Chem. 260, 3440-3450[Abstract/Free Full Text]
24. Rossier, M. F., Krause, K.-H., Lew, P. D., Capponi, A. M., and Vallotton, M. B. (1987) J. Biol. Chem. 262, 4053-4058[Abstract/Free Full Text]
25. Lang, U., and Vallotton, M. B. (1987) J. Biol. Chem. 262, 8047-8050[Abstract/Free Full Text]
26. Meyer, T., Regenass, U., Fabbro, D., Alteri, E., Rosel, J., Muller, M., Caravatti, G., and Matter, A (1989) Int. J. Cancer 43, 851-856[Medline] [Order article via Infotrieve]
27. Herbert, J. M., Augereau, J. M., Gleye, J., and Maffrand, J. P. (1990) Biochem. Biophys. Res. Commun. 172, 993-999[CrossRef][Medline] [Order article via Infotrieve]
28. Bruns, R. F., Miller, F. D., Merriman, R. L., Howbert, J. J., Heath, W. F., Kobayashi, E., Takahashi, I., Tamaoki, T., and Nakano, H. (1991) Biochem. Biophys. Res. Commun. 176, 288-293[CrossRef][Medline] [Order article via Infotrieve]
29. Niisato, N., Post, M., Van Driessche, W., and Marunaka, Y. (1999) Biochem. Biophys. Res. Commun. 266, 547-550[CrossRef][Medline] [Order article via Infotrieve]
30. Roger, F., Martin, P. Y., Rousselot, M., Favre, H., and Feraille, E. (1999) J. Biol. Chem. 274, 34103-34110[Abstract/Free Full Text]
31. Sugden, P. H., and Clerk, A. (1998) Circ. Res. 83, 345-352[Free Full Text]
32. Zhang, Z., and Cohen, D. M. (1996) Am. J. Physiol. 271, F1234-F1238[Medline] [Order article via Infotrieve]
33. Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T., and Saltiel, A. R. (1995) J. Biol. Chem. 270, 27489-27494[Abstract/Free Full Text]
34. Cuenda, A., Rouse, J., Doza, Y. N., Meier, R., Cohen, P., Gallagher, T. F., Young, P. R., and Lee, J. C. (1995) FEBS Lett. 364, 229-233[CrossRef][Medline] [Order article via Infotrieve]
35. Beavo, J. A., Rogers, N. L., Crofford, O. B., Hardman, J. G., Sutherland, E. W., and Newman, E. V. (1970) Mol. Pharmacol. 6, 597-603[Abstract/Free Full Text]
36. James, P., Inui, M., Tada, M., Chiesi, M., and Carafoli, E. (1989) Nature 342, 90-92[CrossRef][Medline] [Order article via Infotrieve]
37. Bianchi, C. P. (1961) J. Gen. Physiol. 44, 845-858[Abstract/Free Full Text]
38. Parker, I., and Ivorra, I. (1991) J. Physiol. 433, 229-240[Abstract/Free Full Text]
39. Brown, G. R., Sayers, L. G., Kirk, C. J., Michell, R. H., and Michelangeli, F. (1992) Biochem. J. 282, 309-312[Medline] [Order article via Infotrieve]
40. Bezprozvanny, I., Bezprozvannaya, S., and Ehrlich, B. E. (1994) Mol. Biol. Cell 5, 97-103[Abstract]
41. Prestwich, S. A., and Bolton, T. B. (1995) Br. J. Pharmacol. 114, 602-611[Medline] [Order article via Infotrieve]
42. Hughes, A. D., Hering, S., and Bolton, T. B. (1990) Pflugers Arch. 416, 462-466[CrossRef][Medline] [Order article via Infotrieve]
43. Kramer, R. H., Mokkapatti, R., and Levitan, E. S. (1994) Pflugers Arch. 426, 12-20[CrossRef][Medline] [Order article via Infotrieve]
44. Thastrup, O., Cullen, P. J., Drobak, B. K., Hanley, M. R., and Dawson, A. P. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 2466-2470[Abstract/Free Full Text]
45. Natarajan, R., Lanting, L., Xu, L., and Nadler, J. (1994) Mol. Cell. Endocrinol. 101, 59-66[CrossRef][Medline] [Order article via Infotrieve]
46. Makara, J. K., Petheo, G. L., Toth, A., and Spat, A. (2000) Endocrinology 141, 1705-1710[Abstract/Free Full Text]
47. Kusuhara, M., Takahashi, E., Peterson, T. E., Abe, J., Ishida, M., Han, J., Ulevitch, R., and Berk, B. C. (1998) Circ. Res. 83, 824-831[Medline] [Order article via Infotrieve]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
EndocrinologyHome page
A. J. Casal, S. Ryser, A. M. Capponi, and C. F. Wang-Buholzer
Angiotensin II-Induced Mitogen-Activated Protein Kinase Phosphatase-1 Expression in Bovine Adrenal Glomerulosa Cells: Implications in Mineralocorticoid Biosynthesis
Endocrinology, November 1, 2007; 148(11): 5573 - 5581.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
H. Liu, J. A. Enyeart, and J. J. Enyeart
Angiotensin II inhibits native bTREK-1 K+ channels through a PLC-, kinase C-, and PIP2-independent pathway requiring ATP hydrolysis
Am J Physiol Cell Physiol, August 1, 2007; 293(2): C682 - C695.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. D. Payet, T. L. Goodfriend, L. Bilodeau, C. Mackendale, L. Chouinard, and N. Gallo-Payet
An oxidized metabolite of linoleic acid increases intracellular calcium in rat adrenal glomerulosa cells
Am J Physiol Endocrinol Metab, December 1, 2006; 291(6): E1160 - E1167.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Otis and N. Gallo-Payet
Differential Involvement of Cytoskeleton and Rho-Guanosine 5'-Triphosphatases in Growth-Promoting Effects of Angiotensin II in Rat Adrenal Glomerulosa Cells
Endocrinology, November 1, 2006; 147(11): 5460 - 5469.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. Gambaryan, E. Butt, P. Tas, A. Smolenski, B. Allolio, and U. Walter
Regulation of aldosterone production from zona glomerulosa cells by ANG II and cAMP: evidence for PKA-independent activation of CaMK by cAMP
Am J Physiol Endocrinol Metab, March 1, 2006; 290(3): E423 - E433.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
D. Cartier, S. Jegou, F. Parmentier, I. Lihrmann, E. Louiset, J.-M. Kuhn, C. Bastard, P.-F. Plouin, M. Godin, H. Vaudry, et al.
Expression profile of serotonin4 (5-HT4) receptors in adrenocortical aldosterone-producing adenomas
Eur. J. Endocrinol., December 1, 2005; 153(6): 939 - 947.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Otis, S. Campbell, M. D. Payet, and N. Gallo-Payet
Angiotensin II Stimulates Protein Synthesis and Inhibits Proliferation in Primary Cultures of Rat Adrenal Glomerulosa Cells
Endocrinology, February 1, 2005; 146(2): 633 - 642.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
A. SPAT and L. HUNYADY
Control of Aldosterone Secretion: A Model for Convergence in Cellular Signaling Pathways
Physiol Rev, April 1, 2004; 84(2): 489 - 539.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Suzuki, F. Otsuka, K. Inagaki, M. Takeda, T. Ogura, and H. Makino
Novel Action of Activin and Bone Morphogenetic Protein in Regulating Aldosterone Production by Human Adrenocortical Cells
Endocrinology, February 1, 2004; 145(2): 639 - 649.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
N. Lalevee, V. Resin, S. Arnaudeau, N. Demaurex, and M. F. Rossier
Intracellular Transport of Calcium from Plasma Membrane to Mitochondria in Adrenal H295R Cells: Implication for Steroidogenesis
Endocrinology, October 1, 2003; 144(10): 4575 - 4585.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Campbell, M. Otis, M. Cote, N. Gallo-Payet, and M. D. Payet
Connection between Integrins and Cell Activation in Rat Adrenal Glomerulosa Cells: A Role for Arg-Gly-Asp Peptide in the Activation of the p42/p44mapk Pathway and Intracellular Calcium
Endocrinology, April 1, 2003; 144(4): 1486 - 1495.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Gu, Y. Wen, A. Mison, and J. L. Nadler
12-Lipoxygenase Pathway Increases Aldosterone Production, 3',5'-Cyclic Adenosine Monophosphate Response Element-Binding Protein Phosphorylation, and p38 Mitogen-Activated Protein Kinase Activation in H295R Human Adrenocortical Cells
Endocrinology, February 1, 2003; 144(2): 534 - 543.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/27/24265    most recent
M110947200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Startchik, I.
Right arrow Articles by Rossier, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Startchik, I.
Right arrow Articles by Rossier, M. F.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement